Rigel Pharmaceuticals reported $26.98M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US $ 18.91M 39K
Amgen AMGN:US $ 1.33B 99M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Applied Genetic Technologies AGTC:US $ 4.32M 494K
Arrowhead Research ARWR:US $ 32.74M 1.12M
AstraZeneca AZN:LN 3.27B 209M
Astrazeneca AZN:US 3.27B 209M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Celldex Therapeutics CLDX:US $ 7.15M 243K
Chemocentryx CCXI:US $ 28.18M 2.17M
Daiichi Sankyo 4568:JP 96.37B 8.36B
Eli Lilly And LLY:US $ 1.63B 67.2M
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Heron Therapeutics HRTX:US $ 32.12M 836K
Immunogen IMGN:US $ 23.79M 7.14M
Intrexon XON:US $ 12.67M 6.91M
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Macrogenics MGNX:US $ 13.67M 2.58M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Pfizer PFE:US $ 3.2B 506M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Rigel Pharmaceuticals RIGL:US $ 26.98M 420K
Sangamo Biosciences SGMO:US $ 15.09M 185K
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
Veracyte VCYT:US $ 39.96M 4.18M